Fundraising Fox
Akouos
Brookline, US · Founded 2017 · Delaware corporation · 45 employees on LinkedIn · 9 known investors
Find your way into Akouos
Akouos is a precision genetic medicine company developing therapies for the inner ear to restore, improve, and preserve hearing. It focuses on treating the underlying causes of hearing loss, including genetic hearing loss.
Founders & leadership
Akouos was founded in 2017 by Emmanuel Simons and william sewell.
Board
Investors · 9
How we know: 5AM Ventures's portfolio page · a partner's Signal profile · board seat on SEC Form D · funding news · press coverage · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: board seat on SEC Form D · press coverage · Not right? Tell us
How we know: Pivotal Life Sciences's portfolio page · funding news · Not right? Tell us
How we know: RA Capital's portfolio page · press coverage · Not right? Tell us
How we know: Sofinnova Ventures's portfolio page · press coverage · the VCSheet dataset · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: press coverage · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$137.7M disclosed across 3 rounds · 2017–2020
▶$105.1MraisedMar 2020 · 33 investors · BiotechnologyRule 506(b)
- Ed MathersDirector
- Kush ParmarDirector
- Karoline ShairExecutive Officer
- Chris SmithDirector
- Heather PrestonDirector
- Vicki SatoDirector
- Aninda KatragaddaExecutive Officer
- Emmanuel SimonsExecutive Officer, Director
- Arthur TzianabosDirector
- Offering amount
- $105.1M
- Amount sold
- $105.1M
- First sale
- Feb 2020
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
▶$25.1MraisedAug 2018 · 10 investors · BiotechnologyRule 506(b)
- Chris SmithDirector
- Emmanuel SimonsExecutive Officer, Director
- Arthur TzianabosDirector
- Ed MathersDirector
- Kush ParmarDirector
- Offering amount
- $50.1M
- Amount sold
- $25.1M
- First sale
- Jul 2018
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$7.6MraisedNov 2017 · 8 investors · BiotechnologyRule 506(b)
- Emmanuel SimonsExecutive Officer, Director
- Ed MathersDirector
- Kush ParmarDirector
- Offering amount
- $7.6M
- Amount sold
- $7.6M
- First sale
- Oct 2017
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Akouos went on to found or lead other companies.
Competitors · 2
by search overlap
Companies competing with Akouos for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Akouos do?
- Akouos is a precision genetic medicine company developing therapies for the inner ear to restore, improve, and preserve hearing. It focuses on treating the underlying causes of hearing loss, including genetic hearing loss.
- Who founded Akouos?
- Akouos was founded by Emmanuel Simons, william sewell in 2017.
- Who are Akouos's investors?
- Akouos's investors include 5AM Ventures, EcoR1 Capital, New Enterprise Associates (NEA), Pivotal Life Sciences, RA Capital, Sofinnova Ventures, Cowen Healthcare Investments, Fidelity Investments and 1 more.
- How much funding has Akouos raised?
- Akouos has disclosed $137.7M raised across 3 rounds.
- Where is Akouos headquartered?
- Akouos is headquartered in Brookline, US.